Study identifies characteristics that may constitute the MS prodromeFebruary 11, 2018Multiple Sclerosis
VIDEO: Teriflunomide and dimethyl fumarate are comparable in relapsing-remitting MSFebruary 9, 2018Multiple Sclerosis
‘Real-world evidence’ used to compare agents for relapsing-remitting MSFebruary 7, 2018Multiple Sclerosis
Rituximab May Provide Greater Benefits Than Other First-Line MS TherapiesFebruary 5, 2018Multiple Sclerosis
